Maxis AI launches MaxisAI Holarchy, the first Verticalized Context Layer for life sciences.Learn More

    AGENTIC AI IN CLINICAL TRIALS

    The First AI WORKFORCE for Clinical Trials

    Maxis AI delivers Agentic AI in Life Sciences through the industry's first AI Workforce for Clinical Trials. Built for sponsors, CRO delivery teams, and site networks, it enables governed clinical execution through reasoning, supervised execution, and human oversight across regulated clinical research workflows. Explore the model in our complete guide to AI agents in clinical trials.

    Maxis AI delivers Agentic AI in Life Sciences through the industry's first AI Workforce for Clinical Trials. Built for sponsors, CROs, and site networks, it enables governed clinical execution through reasoning, supervised execution, and human oversight across regulated clinical research workflows.

    TRUSTED ACROSS SPONSORS, CROS & SITE NETWORKS

    Flourish Research
    Duke Clinical Research Institute
    African Clinical Research Network
    Lexeo Therapeutics
    Teva
    Johnson & Johnson
    Roche
    CooperVision
    Alector
    Denali Therapeutics
    PMI
    BlueRock Therapeutics
    Zydus
    Sage Therapeutics
    Flourish Research
    Duke Clinical Research Institute
    African Clinical Research Network
    Lexeo Therapeutics
    Teva
    Johnson & Johnson
    Roche
    CooperVision
    Alector
    Denali Therapeutics
    PMI
    BlueRock Therapeutics
    Zydus
    Sage Therapeutics
    Flourish Research
    Duke Clinical Research Institute
    African Clinical Research Network
    Lexeo Therapeutics
    Teva
    Johnson & Johnson
    Roche
    CooperVision
    Alector
    Denali Therapeutics
    PMI
    BlueRock Therapeutics
    Zydus
    Sage Therapeutics
    Flourish Research
    Duke Clinical Research Institute
    African Clinical Research Network
    Lexeo Therapeutics
    Teva
    Johnson & Johnson
    Roche
    CooperVision
    Alector
    Denali Therapeutics
    PMI
    BlueRock Therapeutics
    Zydus
    Sage Therapeutics
    Flourish Research
    Duke Clinical Research Institute
    African Clinical Research Network
    Lexeo Therapeutics
    Teva
    Johnson & Johnson
    Roche
    CooperVision
    Alector
    Denali Therapeutics
    PMI
    BlueRock Therapeutics
    Zydus
    Sage Therapeutics
    Flourish Research
    Duke Clinical Research Institute
    African Clinical Research Network
    Lexeo Therapeutics
    Teva
    Johnson & Johnson
    Roche
    CooperVision
    Alector
    Denali Therapeutics
    PMI
    BlueRock Therapeutics
    Zydus
    Sage Therapeutics
    Flourish Research
    Duke Clinical Research Institute
    African Clinical Research Network
    Lexeo Therapeutics
    Teva
    Johnson & Johnson
    Roche
    CooperVision
    Alector
    Denali Therapeutics
    PMI
    BlueRock Therapeutics
    Zydus
    Sage Therapeutics
    Flourish Research
    Duke Clinical Research Institute
    African Clinical Research Network
    Lexeo Therapeutics
    Teva
    Johnson & Johnson
    Roche
    CooperVision
    Alector
    Denali Therapeutics
    PMI
    BlueRock Therapeutics
    Zydus
    Sage Therapeutics
    23

    Years industry experience

    3,300+

    CLINICAL TRIALS

    160+

    Domain & AI experts

    100%

    Pharma/LS focus

    100%

    Renewal rate

    169+

    AI agents

    23+

    Orchestrations

    100+

    System integrations

    Enterprise Compliance21 CFR Part 11SOC 2 Type IIISO 27001ISO 9001HIPAAGDPR
    A

    What is Agentic AI in Life Sciences?

    Agentic AI in Life Sciences refers to AI systems capable of observing, reasoning, planning, and executing regulated clinical workflows while operating within governance, auditability, and human oversight.

    W

    What is an AI Workforce?

    An AI Workforce is a coordinated team of governed AI agents that work alongside clinical teams to execute operational workflows across study startup, data management, safety, regulatory submissions, and quality.

    The Execution Gap

    Visibility is solved. Execution Capacity is the gap.

    Most clinical platforms improve visibility. Few increase execution capacity across regulated operations. Clinical teams don't struggle to see risk anymore. They struggle to resolve it at scale. Digital platforms improved monitoring. They did not increase throughput. Maxis introduces an AI Workforce that converts signals into governed execution. Read why this clinical trial execution gap now drives cost, timeline, and compliance risk.

    Why the shift is needed

    Structural pressure across clinical development.

    Clinical development teams manage increasing protocol complexity, growing data volumes, expanding regulatory expectations, and limited operational capacity. Agentic AI in Clinical Research helps scale execution without proportionally increasing headcount.

    The Solution

    An AI Workforce, working alongside your teams.

    Build your own AI Workforce. Explore our latest stack of AI Agents and Integrations.

    The shift, measured

    AI Workforce Impact Across Clinical Workflows

    Across the workflows that bottleneck most studies, supervised execution compresses the cycle without removing oversight. Routine execution moves faster, while teams stay focused on scientific and operational decisions that require human judgment.

    Workflow turnaround — before vs. after Maxis AI

    Document Production4–6 weeks11h95%
    Document Distribution & Review4–8 weeks55h77%
    Study Preparation & Cohort Selection4–6 weeks20h90%
    Participant Engagement2–4 weeks24h80%
    Data Integration and Reporting8–12 weeks72h82%
    What an AI Workforce is

    A supervised execution layer across regulated workflows.

    Built on four foundational pillars
    How it executes

    Six steps. Every one, traceable.

    A single, supervised execution loop — visible end to end.

    Who we support

    The organizations executing modern clinical trials.

    Trust & Compliance

    Enterprise Security, Compliance and Governance

    Maxis AI operates within the standards regulated clinical environments require — independently audited, fully traceable across every framework that matters.

    Key Safeguards

    Controls built into every layer.

    The execution model is governed by design — not bolted on after.

    Where AI Agents deliver impact

    AI Workforce Use Cases Across Clinical Trials

    Platform Architecture

    Agentic AI Platform Architecture for Clinical Trials

    Six purpose-built layers — scroll to see each one stack into place, from the agents you interact with down to the compliance foundation governing every action.

    Testimonials

    Loved by teams that scale fast.

    Real stories from teams who streamlined workflows and delivered more with less.

    Customer testimonials

    Principal Investigator — Clinical Research Network: Clinical trials are the engine of medical progress, but they are still built on slow, manual, and fragmented processes. The Maxis AI project shows that AI can be harnessed responsibly to modernize that engine — and we're just getting started.

    CEO — Clinical Research Network: Building globally competitive clinical research in Africa requires more than infrastructure — it requires coordinated, scalable execution. Leveraging Maxis AI, we see a clear opportunity to streamline fragmented regulatory processes and accelerate trial starts.

    Clinical Research Leader — Clinical Research Organization: Study startup has remained one of the most persistent bottlenecks in clinical trials. The real opportunity now lies in applying intelligent AI-driven workflows to remove operational friction and accelerate the path from protocol to patient.

    FAQ

    All you need to know.

    Common questions about deploying governed agentic AI in regulated clinical environments.

    Agentic AI in Life Sciences refers to AI systems that can observe, reason, plan and execute regulated clinical workflows under governance controls and human oversight. Unlike traditional AI that primarily generates insights, Agentic AI completes structured operational work across clinical research, helping organizations increase execution capacity while maintaining compliance, auditability and regulatory readiness.

    Maxis AI is the first AI Workforce for Clinical Trials. AI Workforce for Clinical Trials applies Agentic AI in Life Sciences to execute operational work rather than simply reporting on it. Governed AI agents perform structured tasks across study startup, clinical data management, statistical programming, medical writing, safety and quality while working within existing clinical systems and maintaining complete audit traceability.

    Clinical trials generate more operational work than teams can manually resolve as studies become increasingly complex. The role of Agentic AI in Life Sciences is to execute structured, repeatable tasks such as query resolution, startup documentation, workflow coordination and medical writing support, enabling organizations to improve execution capacity without proportionally increasing headcount.

    Agentic AI in Clinical Research improves trial execution by coordinating structured workflows across study startup, clinical operations, data management, safety, statistical programming and regulatory documentation. Governed AI agents execute approved tasks, escalate exceptions and support clinical teams with supervised execution, helping improve consistency, quality and delivery timelines.

    Traditional AI solutions identify risks, generate predictions or surface insights, leaving clinical teams to complete the operational work. Maxis AI introduces an AI Workforce for Clinical Trials that executes approved workflows through governed AI agents. This supervised execution model helps organizations move beyond visibility by increasing operational throughput while maintaining compliance and human oversight.

    Agentic AI in Life Sciences is designed for pharmaceutical companies, biotechnology organizations, contract research organizations (CROs), functional service providers and clinical trial site networks. It supports regulated functions including clinical operations, clinical data management, biostatistics, medical writing, safety, regulatory and quality where governance and audit-ready execution are essential.

    No. Maxis AI is designed to augment clinical teams rather than replace them. The AI Workforce executes structured operational work within defined workflow boundaries while experts retain control over decisions, approvals and exceptions. Human validation checkpoints, governance policies and audit traceability ensure every workflow remains compliant, transparent and accountable.

    Traditional AI helps clinical teams analyze information, generate content, or identify potential risks, but the responsibility for completing operational work still rests with people. An AI Workforce for Clinical Trials extends beyond recommendations by executing structured workflows under human supervision. Governed AI agents coordinate activities across study startup, clinical operations, data management, biometrics, medical writing, and quality while maintaining audit trails, validation checkpoints, and regulatory oversight.